The immediate objective of the country visit to Senegal was to build upon the public health preparedness already in place and to ensure that systems are available to investigate and report potential EVD cases and to mount an effective response to prevent a larger outbreak. The joint team for strengt...hening preparedness for EVD was composed of representatives of Senegal’s Ministry of Health, WHO, CDC, the United Nations Office for Coordination of Humanitarian Affairs, the European Centres for Disease Prevention and Control, the Erasmus Medical Centre, Netherlands, and John Hopkins University, USA.
more
BMC Public Health (2018) 18:668 https://doi.org/10.1186/s12889-018-5594-3
This background document (EUR/RC72/BG/7) was considered and adopted by the WHO Regional Committee for Europe at its 72nd session (Tel Aviv, Israel, 12–14 September 2022), together with the working document (EUR/RC72/7) and information document (EUR/RC72/INF./4). The Regiona...l Committee adopted resolution EUR/RC72/R3, in which it endorsed the framework.
more
Principes directeurs à l’intention des programmes nationaux et autres partenaires
Eur Respir J 2016; 48: 808–817 | DOI: 10.1183/13993003.00840-2016
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
ERJ Open Res 2017; 3: 00002-2017
Clinical Guidance across the continuum of care
Chapter 8_ARV Guidelines
Supplement Article
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018 www.jaids.com
DHS Analytical Studies No. 40